2 Results for "

REV7/REV3L-IN-1

" in MedChemExpress (MCE) Product Catalog:
Products (2)

2 Results for "REV7/REV3L-IN-1" in MCE Product Catalog:

1
1 Cited Publications
Cat. No.: HY-100468
CAS No.: 1979192-13-6
Purity:  99.14%
Target:  

DNA/RNA Synthesis

Research Areas:  

Cancer

REV7/REV3L-IN-1 is a REV7/REV3L interaction inhibitor with an IC50 of 78 μM. REV7/REV3L-IN-1 binds directly to REV7 and inhibits its interaction with REV3L. REV7/REV3L-IN-1 inhibits interstrand crosslink repair in cells. REV7/REV3L-IN-1 chemosensitizes cancer cells to Cisplatin (HY-17394). REV7/REV3L-IN-1 can be used in cervical cancer research .
loading...
    loading...
Cat. No.: HY-100468R
CAS No.: 1979192-13-6
Research Areas:  

Cancer

REV7/REV3L-IN-1 (Standard) is the analytical standard of REV7/REV3L-IN-1 (HY-100468). This product is intended for research and analytical applications. REV7/REV3L-IN-1 is a REV7/REV3L interaction inhibitor with an IC50 of 78 μM. REV7/REV3L-IN-1 binds directly to REV7 and inhibits its interaction with REV3L. REV7/REV3L-IN-1 inhibits interstrand crosslink repair in cells. REV7/REV3L-IN-1 chemosensitizes cancer cells to Cisplatin (HY-17394). REV7/REV3L-IN-1 can be used in cervical cancer research .
loading...
    loading...